We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$438B
AUM Growth
-$46.9M
Cap. Flow
-$1.63B
Cap. Flow %
-0.37%
Top 10 Hldgs %
18.2%
Holding
5,542
New
462
Increased
1,879
Reduced
2,145
Closed
563
Avg Time Held Equity + Options
9 quarters
Top 10 Avg Time Held Equity + Options
10 quarters
Top 20 Avg Time Held Equity + Options
8.6 quarters
Avg Time Held Equity only
9.7 quarters
Top 10 Avg Time Held Equity only
10.9 quarters
Top 20 Avg Time Held Equity only
8.9 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 22.9%
2 Financials 14.86%
3 Technology 11.73%
4 Healthcare 9.66%
5 Consumer Discretionary 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PRGO icon
2201
Perrigo
PRGO
$1.98B
$6.33M ﹤0.01%
83,822
+10,461
+14% +$750K
2013 Q2
16 quarters
ATHN
2202
CALL
DELISTED
Athenahealth, Inc.
ATHN
$6.33M ﹤0.01%
45,000
– –
2016 Q4
2 quarters
ATHN
2203
PUT
DELISTED
Athenahealth, Inc.
ATHN
$6.33M ﹤0.01%
45,000
– –
2016 Q4
2 quarters
GTN icon
2204
Gray Television
GTN
$481M
$6.32M ﹤0.01%
461,610
+336,726
+270% +$4.54M
2015 Q2
8 quarters
TISI icon
2205
Team
TISI
$129M
$6.32M ﹤0.01%
26,948
+3,764
+16% +$968K
2013 Q2
16 quarters
CWEN icon
2206
Clearway Energy Class C
CWEN
$6.2B
$6.3M ﹤0.01%
357,832
+250,970
+235% +$4.4M
2013 Q3
15 quarters
PMC
2207
DELISTED
PharMerica Corporation
PMC
$6.28M ﹤0.01%
239,290
-31,479
-12% -$774K
2013 Q2
16 quarters
EXEL icon
2208
Exelixis
EXEL
$14.3B
$6.28M ﹤0.01%
254,833
-181,933
-42% -$3.85M
2016 Q1
5 quarters
ACWX icon
2209
iShares MSCI ACWI ex US ETF
ACWX
$17.7B
$6.26M ﹤0.01%
137,414
+6,677
+5% +$302K
2013 Q2
16 quarters
AGC
2210
DELISTED
Advent Claymore Conv Sec & Incme
AGC
$6.25M ﹤0.01%
1,003,308
+22,322
+2% +$139K
2013 Q2
16 quarters
HCC icon
2211
Warrior Met Coal
HCC
$4.78B
$6.25M ﹤0.01%
+364,856
New +$6.34M
2017 Q2
0 quarters
DLB icon
2212
Dolby
DLB
$5.5B
$6.25M ﹤0.01%
127,589
-98,609
-44% -$5.03M
2015 Q4
6 quarters
MYOK
2213
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$6.24M ﹤0.01%
476,575
+242,408
+104% +$3.19M
2016 Q1
5 quarters
TCO
2214
DELISTED
Taubman Centers Inc.
TCO
$6.24M ﹤0.01%
104,801
-131,216
-56% -$8.09M
2013 Q2
16 quarters
RAD
2215
DELISTED
Rite Aid Corporation
RAD
$6.2M ﹤0.01%
105,099
-192,950
-65% -$14.6M
2013 Q2
16 quarters
PYPL icon
2216
PUT
PayPal
PYPL
$46.8B
$6.19M ﹤0.01%
115,400
-4,200
-4% -$206K
2015 Q3
7 quarters
NYRT
2217
DELISTED
New York REIT, Inc.
NYRT
$6.19M ﹤0.01%
71,624
-61,273
-46% -$5.56M
2015 Q4
6 quarters
WTI icon
2218
W&T Offshore
WTI
$546M
$6.18M ﹤0.01%
3,152,900
+3,132,143
+15,090% +$6.82M
2016 Q4
2 quarters
HTZ
2219
PUT
DELISTED
Hertz Global Holdings, Inc.
HTZ
$6.17M ﹤0.01%
617,281
+615,439
+33,411% +$6.62M
2017 Q1
1 quarter
JSD
2220
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
$6.15M ﹤0.01%
352,058
+6,140
+2% +$110K
2014 Q4
10 quarters
CPLA
2221
DELISTED
Capella Education Company
CPLA
$6.14M ﹤0.01%
71,727
-13,450
-16% -$1.2M
2013 Q2
16 quarters
NLY icon
2222
Annaly Capital Management
NLY
$13.7B
$6.13M ﹤0.01%
127,253
-210,644
-62% -$9.94M
2013 Q2
16 quarters
SNDX icon
2223
Syndax Pharmaceuticals
SNDX
$1.53B
$6.13M ﹤0.01%
439,070
+435,207
+11,266% +$4.97M
2016 Q4
2 quarters
VATE icon
2224
INNOVATE Corp
VATE
$98.4M
$6.12M ﹤0.01%
104,140
-604
-0.6% -$34.7K
2016 Q2
4 quarters
GDS icon
2225
GDS Holdings
GDS
$6.08B
$6.12M ﹤0.01%
660,047
+274,345
+71% +$2.22M
2017 Q1
1 quarter

Similar funds

JP Morgan Chase's Q2 2017 Portfolio in Review

As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.

By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

  • JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
  • JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
  • JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
  • JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
  • JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
  • JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.

Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.